Botanical species · safety record

Gaultheria fragrantissima

The EFSA Compendium of Botanicals holds 10 constituent measurements for Gaultheria fragrantissima. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Gaultheria fragrantissima Wall.

10Constituent measurements
0Safety records
4Cited sources
5Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 5 licensed products naming Gaultheria fragrantissima as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Gaultheria fragrantissima - Leaf
  • Leaf
  • Whole plant

What the records describe

Constituents measured

  • Methyl salicylate4
  • Alkaloids1
  • Cardiac glycosides1
  • Quinones1
  • Salicylic acid1
  • Saponins1
  • Sterols, total1

Plant parts

  • Leaves7
  • Stem2
  • stalk2
  • Flowering top1

Preparations

  • Solvent extraction6
  • Essential oil4

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsLeavesSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
Cardiac glycosidesLeavesSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
QuinonesLeavesSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
Salicylic acidStem / stalkSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
SaponinsLeavesSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
Sterols, totalLeavesSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
Methyl salicylateStem / stalkEssential oil99.5 PercentGC-MSNo resolvable identifier
Methyl salicylateLeavesEssential oil99.8 PercentGC-MSNo resolvable identifier
Methyl salicylateLeavesEssential oil98 PercentGaschromatography (GC)No resolvable identifier
Methyl salicylateFlowering topEssential oil99.4 PercentGC-MSNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Pandey, B.P., Thapa, R., Upreti, A. Chemical composition, antioxidant and antibacterial activities of essential oil and methanol extract of Artemisia vulgaris and Gaultheria fragrantissima collected from Nepal. Asian pacific journal of tropical medicine, 2017. DOI
  2. Rana, V. S., Verdeguer, M., Blazquez, M. A. Methyl salicylate: a major constituent of the leaves, flowering twigs and stems of Gaultheria fragrantissima Wall. oils. Indian perfumer, 2009, vol. 53, no. 2, p. 47-48.
  3. Bantawa, P., Da Silva, J. A. T., Ghosh, S. K., Mondal, T. K. Determination of essential oil contents and micropropagation of Gaultheria fragrantissima, an endangered woody aromatic plant of India . Journal of horticultural science & biotechnology, 2011, vol. 86, no. 5, p. 479-485.
  4. Cong, Fei., Joshi, Khem Raj., Devkota, Hari Prasad., Watanabe, Takashi., Yahara, Shoji. Dhasingreoside: new flavonoid from the stems and leaves of Gaultheria fragrantissima . Natural product research, 2015, vol. 29, no. 15, p. 1442-1448. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue